Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022067457> ?p ?o ?g. }
- W2022067457 endingPage "431" @default.
- W2022067457 startingPage "425" @default.
- W2022067457 abstract "Cysteinyl-leukotrienes (cysLTs) and thromboxane A(2) (TXA(2)) are important mediators in inflammatory lung diseases such as bronchial asthma and idiopathic pulmonary fibrosis (IPF). We examined the effects of inhaled KP-496, a novel dual antagonist of the cysLTs and TXA(2) receptors, on bleomycin-induced IPF in mice. Mice were intravenously injected bleomycin on day 0, and 0.5% of KP-496 was inhaled twice a day (30 min/time) for the entire experimental period. The effects of KP-496 were evaluated by the number of infiltrated cells in bronchoalveolar lavage fluid (BALF), hydroxyl-L-proline content in the lung, and histopathology. Analyses of BALF on days 7 and 21 revealed that inhaled KP-496 significantly decreased total cell numbers, macrophages, neutrophils, and eosinophils on both days. KP-496 significantly decreased hydroxyl-L-proline content in the lung on day 21. Histopathological analyses of lungs on day 21 demonstrated that KP-496 significantly suppressed inflammatory and fibrotic changes. Our results suggested that the suppression of cysLTs and TXA(2) pathways by KP-496 could control airway inflammation and pulmonary fibrosis, and that KP-496 could be a new therapeutic agent for lung diseases with inflammation and fibrogenesis such as IPF and chronic obstructive pulmonary disease." @default.
- W2022067457 created "2016-06-24" @default.
- W2022067457 creator A5003529714 @default.
- W2022067457 creator A5005361673 @default.
- W2022067457 creator A5008744092 @default.
- W2022067457 creator A5016273788 @default.
- W2022067457 creator A5022602781 @default.
- W2022067457 creator A5026145268 @default.
- W2022067457 creator A5063442204 @default.
- W2022067457 creator A5063586448 @default.
- W2022067457 date "2010-10-01" @default.
- W2022067457 modified "2023-09-24" @default.
- W2022067457 title "Effect of inhaled KP-496, a novel dual antagonist of the cysteinyl leukotriene and thromboxane A2 receptors, on a bleomycin-induced pulmonary fibrosis model in mice" @default.
- W2022067457 cites W1555221659 @default.
- W2022067457 cites W1870393463 @default.
- W2022067457 cites W1879089985 @default.
- W2022067457 cites W1934130721 @default.
- W2022067457 cites W1936798053 @default.
- W2022067457 cites W1963975820 @default.
- W2022067457 cites W1973352042 @default.
- W2022067457 cites W1974783945 @default.
- W2022067457 cites W1983262394 @default.
- W2022067457 cites W1983366269 @default.
- W2022067457 cites W1994164677 @default.
- W2022067457 cites W2003649426 @default.
- W2022067457 cites W2008473978 @default.
- W2022067457 cites W2013295026 @default.
- W2022067457 cites W2017376355 @default.
- W2022067457 cites W2017695218 @default.
- W2022067457 cites W2022835881 @default.
- W2022067457 cites W2026501434 @default.
- W2022067457 cites W2027180323 @default.
- W2022067457 cites W2029708363 @default.
- W2022067457 cites W2030294437 @default.
- W2022067457 cites W2031002970 @default.
- W2022067457 cites W2037029487 @default.
- W2022067457 cites W2037147625 @default.
- W2022067457 cites W2053786000 @default.
- W2022067457 cites W2055931484 @default.
- W2022067457 cites W2055962814 @default.
- W2022067457 cites W2065977597 @default.
- W2022067457 cites W2082515801 @default.
- W2022067457 cites W2085604666 @default.
- W2022067457 cites W2096768293 @default.
- W2022067457 cites W2098640188 @default.
- W2022067457 cites W2111791469 @default.
- W2022067457 cites W2116594128 @default.
- W2022067457 cites W2121910720 @default.
- W2022067457 cites W2123302793 @default.
- W2022067457 cites W2130098255 @default.
- W2022067457 cites W2131763065 @default.
- W2022067457 cites W2139727870 @default.
- W2022067457 cites W2146319740 @default.
- W2022067457 cites W2148211902 @default.
- W2022067457 cites W2149805942 @default.
- W2022067457 cites W2153538099 @default.
- W2022067457 cites W2159197190 @default.
- W2022067457 cites W2160712143 @default.
- W2022067457 cites W2171451814 @default.
- W2022067457 cites W2403488629 @default.
- W2022067457 cites W2766240094 @default.
- W2022067457 cites W2993221855 @default.
- W2022067457 cites W4250358357 @default.
- W2022067457 doi "https://doi.org/10.1016/j.pupt.2010.04.008" @default.
- W2022067457 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20457270" @default.
- W2022067457 hasPublicationYear "2010" @default.
- W2022067457 type Work @default.
- W2022067457 sameAs 2022067457 @default.
- W2022067457 citedByCount "9" @default.
- W2022067457 countsByYear W20220674572013 @default.
- W2022067457 countsByYear W20220674572016 @default.
- W2022067457 countsByYear W20220674572018 @default.
- W2022067457 countsByYear W20220674572019 @default.
- W2022067457 countsByYear W20220674572021 @default.
- W2022067457 countsByYear W20220674572022 @default.
- W2022067457 crossrefType "journal-article" @default.
- W2022067457 hasAuthorship W2022067457A5003529714 @default.
- W2022067457 hasAuthorship W2022067457A5005361673 @default.
- W2022067457 hasAuthorship W2022067457A5008744092 @default.
- W2022067457 hasAuthorship W2022067457A5016273788 @default.
- W2022067457 hasAuthorship W2022067457A5022602781 @default.
- W2022067457 hasAuthorship W2022067457A5026145268 @default.
- W2022067457 hasAuthorship W2022067457A5063442204 @default.
- W2022067457 hasAuthorship W2022067457A5063586448 @default.
- W2022067457 hasConcept C126322002 @default.
- W2022067457 hasConcept C142724271 @default.
- W2022067457 hasConcept C203014093 @default.
- W2022067457 hasConcept C2776042228 @default.
- W2022067457 hasConcept C2776232574 @default.
- W2022067457 hasConcept C2776452501 @default.
- W2022067457 hasConcept C2776694085 @default.
- W2022067457 hasConcept C2776785769 @default.
- W2022067457 hasConcept C2776914184 @default.
- W2022067457 hasConcept C2777714996 @default.
- W2022067457 hasConcept C2777961210 @default.
- W2022067457 hasConcept C2778341716 @default.
- W2022067457 hasConcept C2780559512 @default.
- W2022067457 hasConcept C2781024287 @default.